Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dusseldorf - Delayed Quote EUR

Intellia Therapeutics Inc (38I.DU)

7.07
-0.23
(-3.20%)
As of 7:30:09 PM GMT+2. Market Open.
Loading Chart for 38I.DU
  • Previous Close 7.30
  • Open 7.01
  • Bid 7.14 x --
  • Ask 7.23 x --
  • Day's Range 7.01 - 7.15
  • 52 Week Range 5.47 - 24.98
  • Volume 0
  • Avg. Volume 16
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 38I.DU

View More

Performance Overview: 38I.DU

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

38I.DU
37.73%
S&P 500 (^GSPC)
6.84%

1-Year Return

38I.DU
64.31%
S&P 500 (^GSPC)
8.04%

3-Year Return

38I.DU
84.90%
S&P 500 (^GSPC)
28.27%

5-Year Return

38I.DU
43.37%
S&P 500 (^GSPC)
93.15%

Compare To: 38I.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 38I.DU

View More

Valuation Measures

Annual
As of 4/23/2025
  • Market Cap

    737.81M

  • Enterprise Value

    393.06M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.16

  • Price/Book (mrq)

    0.98

  • Enterprise Value/Revenue

    7.71

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 38I.DU

View More

Company Insights: 38I.DU

Research Reports: 38I.DU

View More